BAP1 and cholangiocarcinoma: We previously demonstrated that BAP1 loss characterized a cholangiocarcinoma-like (CHOL-like) expression-based subset of liver hepatocellular carcinomas and hypothesized that CHOL-like liver tumors represented BAP1-driven changes resembling a transdifferentiated cell phenotype (13).